⠀
• Q2 adjusted sales reached DKK 78.49 billion and adjusted operating profit totaled DKK 33.39 billion, with sales up 7% and operating profit up 11% at constant exchange rates.
• Novo Nordisk expects full-year adjusted sales growth of -6% to 0% at constant exchange rates, broadly in line with market expectations of -5.9%.
• The company also forecasts full-year adjusted operating profit growth of -6% to 0% at constant exchange rates.